Lyophilized formulatons of engineered anti-IL-23p19 antibodies
- 专利权人:
- Merck Sharp & Dohme Corp.
- 发明人:
- Li, Xuhong,Kashi, Ramesh S.,Badkar, Aniket
- 申请号：
- AU2009288419
- 公开号：
- AU2009288419B2
- 申请日:
- 2009.08.25
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要：
- The present invention provides lyophilized formulations of antibodies, such as antibodies that specifically bind to human interleukin-23 p19 (IL-23p19), or antigen binding fragments thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- FORMULATIONS LYOPHILISEES D'ANTICORPS ANTI-IL-23P19 MODIFIES
- Lyophilized formulations of engineered anti-IL-23p19 antibodies
- Engineered lyophilized formulation of anti-IL-23p19 antibody
- FORMULATIONS LYOPHILISEES D'ANTICORPS ANTI-IL-23P19 MODIFIES
- A MONOCLONAL HUMANIZED ANTI-CS1 Luc63 ANTIBODY OR AN ANTI-CS1 Luc63 ANTIGEN BINDING FRAGMENT
